Akademisyen
ALTUĞ YAVAŞOĞLU
PROFESÖR
EGE ÜNİVERSİTESİ TIP FAKÜLTESİ TEMEL TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Histoloji ve Embriyoloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 87
- Proje 0
- Kitap 2
- Bildiri 71
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
17
Q2
25
Q3
9
Q4
2
WoS (JCR)
Q1
12
Q2
6
Q3
15
Q4
19
TR Index
11
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
0
Ort. yüzdelik
42.7%
Üst %1 payı
0.0%
Üst %10 payı
0.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Post-transcriptional knockdown of BRCC3 via siRNA-loaded niosomes modulates autophagy and endoplasmic reticulum stress in rotenone-induced Parkinson’s Disease model YÖKSİS SJR Q1 JCR Q1
- 2026 CD44 Targeting of Cisplatin-Loaded Hyaluronic Acid-Modified Mesoporous Silica Nanoparticles for Lung Adenocarcinoma: Synthesis, Characterization, In Vitro and In Vivo Evaluation YÖKSİS SJR Q1 JCR Q1
- 2026 Endocrine and metabolism modulating effects of paracetamol: From in vitro signaling to in vivo metabolic reprogramming in male mice YÖKSİS SJR Q1 JCR Q1
- 2026 Mitochondrial Dynamics-Related Gene Regulation by Epigenetic Suppression of GCN5 Exerts Neuroprotective Effects in Rotenone-Induced Parkinson’s Disease Model YÖKSİS SJR Q1 JCR Q1
- 2026 Protective effect of (±)-gossypol through modulation of VEGF and apoptosis in mice bearing Ehrlich's solid carcinoma YÖKSİS SJR Q3 JCR Q3 OpenAlex 11.1%
- 2026 Zafirlukast Exacerbates Behavioral Seizure Activity and Blood–Brain Barrier Disruption Despite Modestly Reducing Neuronal Injury Markers in a PTZ-Induced Early Epileptogenesis Mouse Model YÖKSİS SJR Q1 JCR Q1
- 2026 Mitochondrial Dynamics-Related Gene Regulation by Epigenetic Suppression of GCN5 Exerts Neuroprotective Effects in Rotenone-Induced Parkinson’s Disease Model YÖKSİS SJR Q1 JCR Q1
- 2025 Salvia argentea L. extract inhibits the production of NO, and pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), alleviates the inflammatory response of LPS-induced macrophages cells, and reduces the CRP level on carrageenan-induced paw edema YÖKSİS SJR Q1 JCR Q1
- 2025 Dual-drug-loaded magnetic lipid based nanobubbles are effective in non-small cell lung cancer treatment: in vitro and in vivo studies YÖKSİS SJR Q2 JCR Q1
- 2024 Receptor mediated targeting of EGF-conjugated alginate-PAMAM nanoparticles to lung adenocarcinoma: 2D/3D in vitro and in vivo evaluation YÖKSİS SJR Q1 JCR Q1
- 2024 Oxidative stress and inflammatory markers in streptozotocin-induced acute and subacute toxicity response YÖKSİS SJR Q2 JCR Q3
- 2024 Single and repeat-dose toxicity and local tolerance assessment of newly developed oil emulsion adjuvant formulations for veterinary purposes YÖKSİS SJR Q2 JCR Q3
- 2024 Topographic Anatomy and Histology of Inferior Turbinate’s Vascular Structures: A Cadaveric Study YÖKSİS TR Index SJR Q4
- 2023 The Therapeutic Effect of Allopurinol in Fatty Liver Disease in Rats YÖKSİS SJR Q3 JCR Q4
- 2023 Is losartan a promising agent for the treatment of type 1 diabetes-induced testicular germ cell apoptosis in rats? YÖKSİS SJR Q2 JCR Q3
- 2023 Fluvastatin alleviates doxorubicin-induced cardiac and renal toxicity in rats via regulation of oxidative stress, inflammation, and apoptosis associated genes expressions YÖKSİS SJR Q2 JCR Q3
- 2023 Tetrachloromethane Induced Acute Liver Injury in Mice: Biochemical and Histopathological Study of the Hepatoprotective Effect of Hep-X Standardized Botanical Dietary Supplement YÖKSİS SJR Q4 JCR Q4
- 2023 L-glutamic acid-g-poly hydroxyethyl methacrylate nanoparticles: acute and sub-acute toxicity and biodistribution potential in mice YÖKSİS SJR Q3 JCR Q3
- 2022 Oxidative stress-induced apoptotic changes after acute exposure to antifouling agent zinc pyrithione (ZnPT) in Mytilus galloprovincialis Lamark (Mediterranean mussels) tissues YÖKSİS SJR Q2 JCR Q3
- 2022 Effects of ranibizumab and zoledronic acid on endometriosis in a rat model YÖKSİS SJR Q2 JCR Q3 OpenAlex 74.4%